* Harrow Health Inc HROW.OQ reported quarterly adjusted
earnings
of 4 cents per share for the quarter ended in December. The
mean expectation of four analysts for the quarter was for a loss
of 12 cents per share.
* Revenue rose 0.7% to $20.33 million from a year ago;
analysts
expected $21.40 million.
* Harrow Health Inc's reported EPS for the quarter was 4
cents.
* The mean earnings estimate of analysts had fallen by
about 2.9%
in the last three months.
* In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company.
* Harrow Health Inc shares had risen by 17.0% this quarter.
* The company reported quarterly net income of $1.06
million.
* Wall Street's median 12-month price target for Harrow
Health Inc
is $19.25
* The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 4 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell."
This summary was machine generated from LSEG Refinitiv data
March 23 at 09:52 p.m. UTC. All figures in US dollars unless
otherwise stated. QUARTER ENDING ESTIMATE ACTUAL BEAT, MET,
MISSED
Dec. 31 2022 -0.12 0.04 Beat
Sep. 30 2022 0.00 -0.24 Missed
Jun. 30 2022 -0.01 -0.23 Missed
Mar. 31 2022 -0.03 0.03 Beat